(Q37188218)

18 August 2017

The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma (English)

1 reference

18 August 2017

3

Huib N Caron

1 reference

18 August 2017

Godelieve A. M. Tytgat

7

object named as

Godelieve A Tytgat

1 reference

18 August 2017

2

Gitta Bleeker

1 reference

18 August 2017

Reineke A Schoot

1

1 reference

18 August 2017

Berthe L van Eck

4

1 reference

18 August 2017

Hugo A Heij

5

1 reference

18 August 2017

Jan de Kraker

6

1 reference

18 August 2017

6 June 2013

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

18 August 2017

1 reference

18 August 2017

40

1 reference

18 August 2017

10

1 reference

18 August 2017

1516-1522

1 reference

Creative Commons Attribution-NonCommercial 2.0 Generic

18 August 2017

start time

6 June 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00259-013-2455-2

0 references

cites work

Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3779309

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3779309

First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3779309

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3779309

Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3779309

Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3779309

Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma WithoutMYCNAmplification: Results of the Prospective INES 99.1

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-013-2455-2

Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23740371

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23740371

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23740371

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-013-2455-2

1 reference

18 August 2017

1 reference

18 August 2017

1 reference